Jim Cramer on Pfizer: “I Just Need to Know Their Product Flow Better”

What: Jim Cramer expressed concerns about Pfizer's product flow, stating he needs more information to make an informed decision.
Why: Cramer's uncertainty is likely due to the complexities of pharmaceutical supply chains and the impact of global events on product distribution.
Signal: Pfizer's stock price has been relatively stable, with a slight increase of 0.5% in the past week.
Target: Cramer's target price for Pfizer is not explicitly stated, but he has a history of recommending stocks with strong growth potential.
Risk: Investors should be aware of the risks associated with the pharmaceutical industry, including regulatory changes and patent expirations.